Cargando…

A description of antipsychotic prescribing patterns based on race in the inpatient behavioral health setting

BACKGROUND AND AIMS: A growing body of research shows that race contributes to disparities in mental health services utilization and influences the clinical diagnostic process. To our knowledge, no studies on current practice in the Unites States have documented whether these disparities impact the...

Descripción completa

Detalles Bibliográficos
Autores principales: Maestri, Thomas, Anderson, David, Calderon-Abbo, Jose, Waguespack, Taylor, Echeverri, Margarita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239957/
https://www.ncbi.nlm.nih.gov/pubmed/34249329
http://dx.doi.org/10.1177/20451253211023221
_version_ 1783715123144163328
author Maestri, Thomas
Anderson, David
Calderon-Abbo, Jose
Waguespack, Taylor
Echeverri, Margarita
author_facet Maestri, Thomas
Anderson, David
Calderon-Abbo, Jose
Waguespack, Taylor
Echeverri, Margarita
author_sort Maestri, Thomas
collection PubMed
description BACKGROUND AND AIMS: A growing body of research shows that race contributes to disparities in mental health services utilization and influences the clinical diagnostic process. To our knowledge, no studies on current practice in the Unites States have documented whether these disparities impact the prescription of antipsychotic medications across individual patients based on race. Consequently, this study aims to describe the prescribing patterns of antipsychotic medications in the inpatient setting based on patients’ race, and to explore appropriateness of therapy based on Food and Drug Administration labeling and avoidance of inappropriate polypharmacy. METHODS: Single-centered, retrospective, chart review of 398 psychiatric patients in the inpatient setting and who had a psychiatric diagnosis that warranted a prescription for an antipsychotic medication at the time of discharge. Frequencies were computed to describe differences in demographic variables (race, health insurance type, age, and gender), medical conditions (diagnosis, commodities, hospitalization status, antipsychotic medications, etc.), and screening tests (lipid panel, hemoglobin, urine and illicit drug use). Logistic regression, analysis of variance, and hypothesis tests were used to analyze the data. RESULTS: Significant differences were not found in total chlorpromazine equivalent dose equivalencies by race or insurance. However, patients of involuntary admission status, past medication trials, a diagnosis of schizophrenia or bipolar disorder, and who lacked family support had higher total daily doses of antipsychotics upon discharge. Inappropriate therapy was significantly related to differences in increasing age and a diagnosis of insomnia. CONCLUSION: This single-centered study described patterns of antipsychotic prescribing based on race in an inpatient psychiatry facility. Future studies, using larger and more diverse sample populations, are recommended to elucidate the role that patients’ race, admission status, and family support play in the dose and appropriateness of antipsychotics prescribed for mental health care.
format Online
Article
Text
id pubmed-8239957
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-82399572021-07-08 A description of antipsychotic prescribing patterns based on race in the inpatient behavioral health setting Maestri, Thomas Anderson, David Calderon-Abbo, Jose Waguespack, Taylor Echeverri, Margarita Ther Adv Psychopharmacol Original Research BACKGROUND AND AIMS: A growing body of research shows that race contributes to disparities in mental health services utilization and influences the clinical diagnostic process. To our knowledge, no studies on current practice in the Unites States have documented whether these disparities impact the prescription of antipsychotic medications across individual patients based on race. Consequently, this study aims to describe the prescribing patterns of antipsychotic medications in the inpatient setting based on patients’ race, and to explore appropriateness of therapy based on Food and Drug Administration labeling and avoidance of inappropriate polypharmacy. METHODS: Single-centered, retrospective, chart review of 398 psychiatric patients in the inpatient setting and who had a psychiatric diagnosis that warranted a prescription for an antipsychotic medication at the time of discharge. Frequencies were computed to describe differences in demographic variables (race, health insurance type, age, and gender), medical conditions (diagnosis, commodities, hospitalization status, antipsychotic medications, etc.), and screening tests (lipid panel, hemoglobin, urine and illicit drug use). Logistic regression, analysis of variance, and hypothesis tests were used to analyze the data. RESULTS: Significant differences were not found in total chlorpromazine equivalent dose equivalencies by race or insurance. However, patients of involuntary admission status, past medication trials, a diagnosis of schizophrenia or bipolar disorder, and who lacked family support had higher total daily doses of antipsychotics upon discharge. Inappropriate therapy was significantly related to differences in increasing age and a diagnosis of insomnia. CONCLUSION: This single-centered study described patterns of antipsychotic prescribing based on race in an inpatient psychiatry facility. Future studies, using larger and more diverse sample populations, are recommended to elucidate the role that patients’ race, admission status, and family support play in the dose and appropriateness of antipsychotics prescribed for mental health care. SAGE Publications 2021-06-27 /pmc/articles/PMC8239957/ /pubmed/34249329 http://dx.doi.org/10.1177/20451253211023221 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Maestri, Thomas
Anderson, David
Calderon-Abbo, Jose
Waguespack, Taylor
Echeverri, Margarita
A description of antipsychotic prescribing patterns based on race in the inpatient behavioral health setting
title A description of antipsychotic prescribing patterns based on race in the inpatient behavioral health setting
title_full A description of antipsychotic prescribing patterns based on race in the inpatient behavioral health setting
title_fullStr A description of antipsychotic prescribing patterns based on race in the inpatient behavioral health setting
title_full_unstemmed A description of antipsychotic prescribing patterns based on race in the inpatient behavioral health setting
title_short A description of antipsychotic prescribing patterns based on race in the inpatient behavioral health setting
title_sort description of antipsychotic prescribing patterns based on race in the inpatient behavioral health setting
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239957/
https://www.ncbi.nlm.nih.gov/pubmed/34249329
http://dx.doi.org/10.1177/20451253211023221
work_keys_str_mv AT maestrithomas adescriptionofantipsychoticprescribingpatternsbasedonraceintheinpatientbehavioralhealthsetting
AT andersondavid adescriptionofantipsychoticprescribingpatternsbasedonraceintheinpatientbehavioralhealthsetting
AT calderonabbojose adescriptionofantipsychoticprescribingpatternsbasedonraceintheinpatientbehavioralhealthsetting
AT waguespacktaylor adescriptionofantipsychoticprescribingpatternsbasedonraceintheinpatientbehavioralhealthsetting
AT echeverrimargarita adescriptionofantipsychoticprescribingpatternsbasedonraceintheinpatientbehavioralhealthsetting
AT maestrithomas descriptionofantipsychoticprescribingpatternsbasedonraceintheinpatientbehavioralhealthsetting
AT andersondavid descriptionofantipsychoticprescribingpatternsbasedonraceintheinpatientbehavioralhealthsetting
AT calderonabbojose descriptionofantipsychoticprescribingpatternsbasedonraceintheinpatientbehavioralhealthsetting
AT waguespacktaylor descriptionofantipsychoticprescribingpatternsbasedonraceintheinpatientbehavioralhealthsetting
AT echeverrimargarita descriptionofantipsychoticprescribingpatternsbasedonraceintheinpatientbehavioralhealthsetting